TANDEM TRIAL: a factorial randomised controlled trial of dose and review schedule of bevacizumab (Avastin) for neovascular macular degeneration in the East Midlands
Article in BMJ Open Ophthalmology (December 2020)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Article in BMJ Open Ophthalmology (December 2020)
Article in Experimental and Therapeutic Medicine (October 2020)
Article in Cochrane Database of Systematic Reviews (May 2020)